secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001933414-23-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mineralys Therapeutics discloses 2022 executive bonuses and raises 2023 target bonus percentages
--------------------------------------------------------------------------------

- 2022 bonuses: CEO Congleton $193.2k, CFO Levy $190.9k, CMO Rodman $190.8k.
- 2023 target bonuses increased: Congleton 50% of base salary, Rodman 45%, Levy 40%.
- Revised Summary Compensation Table includes previously omitted 2022 bonus amounts.
- Equity awards in 2022: Congleton $1.12M stock, Levy $483.5k stock, Rodman $492k options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341423000024/0001933414-23-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341423000024/mlys202303178k.htm
  HTML page:      https://secwatch.observer/filing/0001933414-23-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer